Jim Simons’s SpringWorks Therapeutics SWTX Stock Holding History

Jim Simons’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-760,600	Closed	-$35.7M	–	3907
2025 Q2	$35.7M	Buy	760,600 +574,700	+309%	+$25.6M	0.05%	459
2025 Q1	$8.2M	Buy	+185,900	New	+$8.56M	0.01%	1116
2022 Q4	–	Sell	-20,400	Closed	-$582K	–	4401
2022 Q3	$582K	Buy	+20,400	New	+$585K	﹤0.01%	2840
2021 Q2	–	Sell	-60,900	Closed	-$4.48M	–	3762
2021 Q1	$4.48M	Buy	60,900 +30,800	+102%	+$2.41M	0.01%	1713
2020 Q4	$2.18M	Buy	30,100 +19,000	+171%	+$1.22M	﹤0.01%	2075
2020 Q3	$529K	Buy	+11,100	New	+$473K	﹤0.01%	2797
2020 Q2	–	Sell	-15,200	Closed	-$410K	–	3762
2020 Q1	$410K	Buy	+15,200	New	+$496K	﹤0.01%	2854

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Jim Simons's SWTX Position: Q3 2025 in Review

Jim Simons sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 760,600 shares — an estimated $35.7M sold.

Jim Simons first reported a position in SWTX in Q1 2020 and held it in 7 quarters. The position peaked at $35.7M in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Jim Simons reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Jim Simons sold 760,600 SpringWorks Therapeutics shares in Q3 2025, an estimated $35.7M.
Jim Simons first reported a position in SpringWorks Therapeutics in Q1 2020 and held it in 7 quarters.
Jim Simons's SpringWorks Therapeutics position peaked at $35.7M in Q2 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Renaissance Technologies's 13F filing for Q3 2025, filed 13 Nov 2025.